Webinar on personalized medicine
Doctor Marthe Kirkesæther Brun talks in this webinar about research findings that can give many patients better treatment. The webinar is entitled Personalized treatment of inflammatory diseases - monitoring drug levels and antibodies.
Premiere 31 August at 0830
You can find the link here, https://youtu.be/2RGv-5Om2-0
In our YouTube channel you can watch several webinars on current topics: //www https://www.youtube.com/@NKRR
We quote from VG's article about Marthe K. Brun's doctorate, 16 May this year:
Many people with chronic inflammatory diseases have experienced that the body forms antibodies against the medicines they need to keep the disease in check. This has resulted in a poorer effect, or in the worst case, that the medicine has stopped working. This, in turn, can lead to a flare-up of the disease, which sets the patients back in terms of health.
But now this patient group can face a brighter future. The background is the so-called NOR-DRUM study, and not least the results of Marthe Kirkesæther Brun's doctoral work, which is linked to this study.
In 2019, Kirkesæther Brun started as a doctoral fellow at the REMEDY research center at Diakonhjemmet Hospital in Oslo. The research center specializes in rheumatology and musculoskeletal diseases, and has been very central to the aforementioned study.
On 25 April this year, she defended and completed her doctoral thesis, which was named "Infliximab therapy in immune-mediated inflammatory diseases: Immunogenicity and proactive therapeutic drug monitoring".
Simply explained, it is about the medicine infliximab and other types of biological treatment that more than 50,000 people with chronic inflammatory diseases in this country receive.
Two out of three who have inflammatory diseases of the joints, and who are treated with these medicines, achieve freedom from symptoms. The research into how the medicine should be used as optimally as possible, as well as the mapping of risk factors that mean that the preparations do not work as expected, means that the last third also now has increased hope for help.
